Evidence map›Paper›PMID 32513914›Full record

ArticleCell death & disease2020

Endogenously produced LG3/4/5-peptide protects testes against toxicant-induced injury.

Linxi Li, Baiping Mao, Siwen Wu, Huitao Li, Lixiu Lv, Renshan Ge, C Yan Cheng

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Linxi LiThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Baiping MaoThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Siwen WuThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Huitao LiThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Lixiu LvThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Renshan GeThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
C Yan ChengThe Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China. yancheng@aol.com.ORCID http://orcid.org/0000-0003-3117-3791
Wenzhou Medical University · CN

Funding

The biology of blood-testis barrier dynamicsR01HD056034 · NICHD · POPULATION COUNCIL · PI CHENG, C. YAN · 2009 to 2018
$3.4M
NICHD NIH HHS R01 HD056034
6 · The paper itself

Abstract

Laminin-α2 chain is one of the major constituent proteins of the basement membrane in the mammalian testis. The laminin-type globular (LG) domains of LG3, 4 and 5 (LG3/4/5, an 80 kDa fragment) can be cleaved from laminin-α2 chain at the C-terminus via the action of matrix metalloproteinase 9 (MMP-9). This LG3/4/5 is a biologically active fragment, capable of modulating the Sertoli cell blood-testis barrier (BTB) function by tightening the barrier both in vitro and in vivo. Overexpression of LG3/4/5 cloned into a mammalian expression vector pCI-neo in Sertoli cells in a Sertoli cell in vitro model with a functional BTB also protected Sertoli cells from cadmium chloride (CdCl

Indexed as

AnimalsCell ProliferationLamininMalePeptide FragmentsProtein DomainsRatsRats, Sprague-DawleySertoli CellsTestisTransfectionLamininlaminin alpha 2Peptide Fragments

Identifiers

PMID32513914
PMCPMC7280515
OpenAlexW3033562135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.